Issue 35, 2022, Issue in Progress

New dimeric chromanone derivatives from the mutant strains of Penicillium oxalicum and their bioactivities

Abstract

Three new chromanone dimer derivatives, paecilins F–H (1–3) and ten known compounds (4–13), were obtained from the mutant strains of Penicillium oxalicum 114-2. Their structures were elucidated by extensive analysis of spectroscopic data and comparison with reported data, and the configurations of 1–3 were resolved by quantum chemical calculations of NMR shifts and ECD spectra. Compounds 5 and 11 showed significant anti-influenza A virus activities with IC50 values of 5.6 and 6.9 μM, respectively. Compounds 8 and 9 displayed cytotoxic activities against the MIA-PaCa-2 cell line with IC50 values of 2.6 and 2.1 μM, respectively. Compound 10 exhibited antibacterial activities against Bacillus cereus with a MIC value of 4 μg mL−1.

Graphical abstract: New dimeric chromanone derivatives from the mutant strains of Penicillium oxalicum and their bioactivities

Supplementary files

Article information

Article type
Paper
Submitted
25 Apr 2022
Accepted
26 Jul 2022
First published
10 Aug 2022
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2022,12, 22377-22384

New dimeric chromanone derivatives from the mutant strains of Penicillium oxalicum and their bioactivities

G. Gu, T. Zhang, J. Zhao, W. Zhao, Y. Tang, L. Wang, S. Cen, L. Yu and D. Zhang, RSC Adv., 2022, 12, 22377 DOI: 10.1039/D2RA02639B

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements